Gene amplifications and deletions frequently contribute to tumorigenesis. Characterization of these DNA copy-number changes is important for both the basic understanding of cancer and its diagnosis. Comparative genomic hybridization (CGH) was developed to survey DNA copy-number variations across a whole genome1. With CGH, differentially labelled test and reference genomic DNAs are co-hybridized to normal metaphase chromosomes, and fluorescence ratios along the length of chromosomes provide a cytogenetic representation of DNA copynumber variation. CGH, however, has a limited (∼20 Mb) mapping resolution, and higher-resolution techniques, such as fluorescence in situ hybridization (FISH), are prohibitively labour-intensive on a genomic scale. ...
Only few selected cancer cells drive tumor progression and are responsible for therapy resistance. T...
Only few selected cancer cells drive tumor progression and are responsible for therapy resistance. T...
Only few selected cancer cells drive tumor progression and are responsible for therapy resistance. T...
Genomic DNA copy number alterations are key genetic events in the development and progression of hum...
Genomic DNA copy number alterations are key genetic events in the development and progression of hum...
In this work, we explore the use of representations in conjunction with DNA microarray technology to...
gene in the Basal-like SUM149 breast cancer cell line.We sought to identify if small regions of gen...
Array comparative genomic hybridization (CGH) has been popularly used for analyzing DNA copy number ...
The development of high-throughput screening methods such as array-based comparative genome hybridiz...
Genomic amplifications and deletions, the consequence of somatic variation, are a hallmark of human ...
At the present time, there is increasing evidence that cancer may be regulated by the number of copi...
Array comparative genomic hybridization (CGH) has been popularly used for analyzing DNA copy number ...
Almost all human cancers as well as developmental abnormalities are characterized by the presence of...
Over the past few years, various reliable platforms for high-resolution detection of DNA copy number...
Over the past few years, various reliable platforms for high-resolution detection of DNA copy number...
Only few selected cancer cells drive tumor progression and are responsible for therapy resistance. T...
Only few selected cancer cells drive tumor progression and are responsible for therapy resistance. T...
Only few selected cancer cells drive tumor progression and are responsible for therapy resistance. T...
Genomic DNA copy number alterations are key genetic events in the development and progression of hum...
Genomic DNA copy number alterations are key genetic events in the development and progression of hum...
In this work, we explore the use of representations in conjunction with DNA microarray technology to...
gene in the Basal-like SUM149 breast cancer cell line.We sought to identify if small regions of gen...
Array comparative genomic hybridization (CGH) has been popularly used for analyzing DNA copy number ...
The development of high-throughput screening methods such as array-based comparative genome hybridiz...
Genomic amplifications and deletions, the consequence of somatic variation, are a hallmark of human ...
At the present time, there is increasing evidence that cancer may be regulated by the number of copi...
Array comparative genomic hybridization (CGH) has been popularly used for analyzing DNA copy number ...
Almost all human cancers as well as developmental abnormalities are characterized by the presence of...
Over the past few years, various reliable platforms for high-resolution detection of DNA copy number...
Over the past few years, various reliable platforms for high-resolution detection of DNA copy number...
Only few selected cancer cells drive tumor progression and are responsible for therapy resistance. T...
Only few selected cancer cells drive tumor progression and are responsible for therapy resistance. T...
Only few selected cancer cells drive tumor progression and are responsible for therapy resistance. T...